AFT gains Australian registration for intravenous Maxigesic

AFT gains Australian registration for intravenous Maxigesic
Jenny Ruth
By Jenny Ruth July 24 (BusinessDesk) - AFT Pharmaceuticals says it has successfully registered the intravenous form of its Maxigesic medication with Australia’s Therapeutic Goods Administration. The intravenous product contains 1,000 milligrams of paracetamol and 300mg of ibuprofen in a 100 millilitre solution. The company says it expects to sell the product in Australia during the year ending March 2020 and the registration “clears the way for regulatory filings in a number of other territories including but not limited to Mexico, Sou...

More Services

Airwork on the block to repay $145m of bank debt
Law & Regulation

Airwork on the block to repay $145m of bank debt

Airwork has an outstanding intercompany loan of $35.83m, owes trade creditors $219,000.

Denise McNabb 11 Sep 2025
Risky Business: understanding NZ’s insurance sector
Services Editor’s note

Risky Business: understanding NZ’s insurance sector

BusinessDesk’s latest special project.

Victoria Young 11 Sep 2025
Assessing Spark's datacentre deal with PEP
Markets Analysis

Assessing Spark's datacentre deal with PEP

Could Spark be paying special dividends before the end of the decade?

Pattrick Smellie 13 Aug 2025
Food Chain report shows $9m owing
Services

Food Chain report shows $9m owing

More than $9.1m is owing in the liquidation of food supplier Food Chain, the first report in the insolvency shows. The company, which has ceased trading, had approximately 60 staff, and is also in receivership. The first liquidators' report of Adam Botterill and Damien Grant...

Staff reporters 11 Jul 2025